Advertisement

Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus

Published:February 12, 2018DOI:https://doi.org/10.1016/j.diabres.2018.02.009

      Abstract

      Aims

      Obesity and ectopic fat accumulation are important conditions of type 2 diabetes mellitus (T2DM). Our aim was to determine whether bioelectrical impedance body composition analysis combined with blood test results could estimate liver ectopic fat accumulation in patients with treatment-naïve T2DM.

      Methods

      Subjects were 119 untreated T2DM patients. Computed tomography scans were performed to calculate the liver to spleen attenuation ratio (L/S ratio) as a measure of liver fat accumulation, with excess liver fat accumulation defined as an L/S ratio <1.0. Elementary body composition was measured by bioelectrical impedance analysis using InBody770.

      Results

      The Nagelkerke R2 test showed that the muscle mass/fat mass ratio (muscle/fat ratio) was the most suitable variable among anthropometric factors and body component indexes for estimating liver fat accumulation. The muscle/fat ratio was significantly correlated with the L/S ratio (ρ = 0.4386, P < 0.0001). Multivariable logistic regression analysis showed that the muscle/fat ratio (odds ratio 0.40, 95% confidence interval 0.22–0.73, P < 0.01) and alanine aminotransferase (odds ratio 1.06, 95% confidence interval 1.02–1.10, P < 0.01) were independently and significantly associated with liver fat accumulation. In receiver operating characteristic curve analysis, the cutoff value of the muscle/fat ratio for excess liver fat accumulation was 2.34.

      Conclusion

      In patients with treatment-naïve T2DM, the muscle/fat ratio and ALT are useful for estimating the presence of excess liver fat accumulation in daily clinical practice.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vernon G.
        • Baranova A.
        • Younossi Z.M.
        Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
        Aliment Pharmacol Ther. 2011; 34: 274-285
        • Kojima H.
        • Sakurai S.
        • Uemura M.
        • Fukui H.
        • Morimoto H.
        • Tamagawa Y.
        Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis.
        Alcohol Clin Exp Res. 2007; 31: S61-6
        • El-Serag H.B.
        • Tran T.
        • Everhart J.E.
        Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.
        Gastroenterology. 2004; 126: 460-468
        • Bril F.
        • Cusi K.
        Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: A CALL TO ACTION.
        Diabetes Care. 2017; 40: 419-430
        • Mantovani A.
        • Targher G.
        Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.
        Ann Transl Med. 2017; 5: 270
        • Hotta N.
        • Nakamura J.
        • Iwamoto Y.
        • Ohno Y.
        • Kasuga M.
        • Kikkawa R.
        • et al.
        Causes of death in Japanese diabetics: a questionnaire survey of 18,385 diabetics over a 10-year period.
        J Diabetes Investig. 2010; 1: 66-76
        • Saadeh S.
        • Younossi Z.M.
        • Remer E.M.
        • Gramlich T.
        • Ong J.P.
        • Hurley M.
        • et al.
        The utility of radiological imaging in nonalcoholic fatty liver disease.
        Gastroenterology. 2002; 123: 745-750
        • Akter Shamima
        • Goto Atsushi
        • Mizoue Tetsuya
        Smoking and the risk of type 2 diabetes in Japan: a systematic review and meta-analysis.
        J Epidemiol. 2017; 27: 553-561
        • Abenavoli L.
        • Luigiano C.
        • Guzzi P.H.
        • Milic N.
        • Morace C.
        • Stelitano L.
        • et al.
        Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.
        Panminerva Med. 2014; 56: 189-193
        • Kato K.
        • Takamura T.
        • Takeshita Y.
        • Ryu Y.
        • Misu H.
        • Ota T.
        • et al.
        Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease.
        PLoS ONE. 2014; 9: e92170
        • Korenblat K.M.
        • Fabbrini E.
        • Mohammed B.S.
        • Klein S.
        Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
        Gastroenterology. 2008; 134: 1369-1375
        • Koda M.
        • Kawakami M.
        • Murawaki Y.
        • Senda M.
        The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies.
        J Gastroenterol. 2007; 42: 897-903
        • Kurinami N.
        • Sugiyama S.
        • Yoshida A.
        • Hieshima K.
        • Miyamoto F.
        • Kajiwara K.
        • et al.
        Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naïve type 2 diabetes mellitus.
        DRCP. 2016; 120: 65-72
        • American Diabetes Association
        Standards of medical care in diabetes—2010.
        Diabetes Care. 2010 Jan; 33: S11-S61
        • Chalasani N.
        • Younossi Z.
        • Lavine J.E.
        • Diehl A.M.
        • Brunt E.M.
        • Cusi K.
        • et al.
        The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and the American College of Gastroenterology.
        Gastroenterology. 2012; 142: 1592-1609
        • Kan H.
        • Kimura Y.
        • Hyogo H.
        • Fukuhara T.
        • Fujino H.
        • Naeshiro N.
        • et al.
        Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease.
        Hepatology Res. 2014; 44: E420-7
        • Cha K.
        • Chertow G.M.
        • Gonzalez J.
        • Lazarus J.M.
        • Wilmore D.W.
        Multifrequency bioelectrical impedance estimates the distribution of body water.
        J Appl Physiol. 1995; 79: 1316-1319
        • Cha K.
        • Shin S.
        • Shon C.
        • Choi S.
        • Wilmore D.W.
        Evaluation of segmental bioelectrical impedance analysis (SIBA) for measuring muscle distribution.
        J ICHPER SD-ASIA. 1997; : 11-14
        • Sanada K.
        • Miyachi M.
        • Tanimoto M.
        • Yamamoto K.
        • Murakami H.
        • Okumura S.
        • et al.
        A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors.
        Eur J Appl Physiol. 2010; 110: 57-65
        • Everhart J.E.
        • Bambha K.M.
        Fatty liver: think globally.
        Hepatology. 2010; 51: 1491-1493
        • Eguchi Y.
        • Eguchi T.
        • Mizuta T.
        • Ide Y.
        • Yasutake T.
        • Iwakiri R.
        • et al.
        Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.
        J Gastroenterol. 2006; 41: 462-469
        • Yamauchi T.
        • Kadowaki T.
        Adiponectin receptor as a key player in healthy longevity and obesity-related diseases.
        Cell Metab. 2013; 17: 185-196
      1. Roldan-Valadez E, Favila R, Martínez-López M, Uribe M, Méndez-Sánchez N. Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease. Ann Hepatol 2008; 7(3): 212–20 [Jul-Sep].

        • Iwasaki M.
        • Takada Y.
        • Hayashi M.
        • Minamiguchi S.
        • Haga H.
        • Maetani Y.
        • et al.
        Noninvasive evaluation of graft steatosis in living donor liver transplantation.
        Transplantation. 2004 Nov 27; 78: 1501-1505
        • Kelley D.E.
        • McKolanis T.M.
        • Hegazi R.A.F.
        • Kuller L.H.
        • Kalhan S.C.
        Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.
        Am J Physiol Endocrinol Metab. 2003; 285: E906-16
        • Yoo H.J.
        • Park M.S.
        • Lee C.H.
        • Yang S.J.
        • Kim T.N.
        • Lim K.I.
        • et al.
        Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians.
        Liver Int. 2010; 30: 1189-1196
        • Ishibashi E.
        • Eguchi Y.
        • Eguchi T.
        • Matsunobu A.
        • Oza N.
        • Nakashita S.
        • et al.
        Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.
        J Gastroenterol Hepatol. 2008; 23: 908-913
        • Cusi K.
        Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
        Gastroenterology. 2012; 142: 711-725
        • Sakurai M.
        • Takamura T.
        • Ota T.
        • Ando H.
        • Akahori H.
        • Kaji K.
        • et al.
        Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease.
        J Gastroenterol. 2007; 42: 312-317
        • Schindhelm R.K.
        • Diamant M.
        • Dekker J.M.
        • Tushuizen M.E.
        • Teerlink T.
        • Heine R.J.
        Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
        Diabetes Metab Res Rev. 2006; 22: 437-443
        • McPherson S.
        • Stewart S.F.
        • Henderson E.
        • Burt A.D.
        • Day C.P.
        Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
        Gut. 2010 Sep; 59: 1265-1269
        • Chang Y.
        • Ryu S.
        • Sung E.
        • Jang Y.
        Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.
        Clin Chem. 2007; 53: 686-692
        • Cruz-Jentoft A.J.
        • Landi F.
        • Schneider S.M.
        • Zúñiga C.
        • Arai H.
        • Boirie Y.
        • et al.
        Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS).
        Age Ageing. 2014; 43: 748-759
        • Santilli V.
        • Bernetti A.
        • Mangone M.
        • Paoloni M.
        Clinical definition of sarcopenia.
        Clin Cases Miner Bone Metab. 2014; 11: 177-180